KR20210039987A - 티피파닙의 합성 - Google Patents

티피파닙의 합성 Download PDF

Info

Publication number
KR20210039987A
KR20210039987A KR1020207036324A KR20207036324A KR20210039987A KR 20210039987 A KR20210039987 A KR 20210039987A KR 1020207036324 A KR1020207036324 A KR 1020207036324A KR 20207036324 A KR20207036324 A KR 20207036324A KR 20210039987 A KR20210039987 A KR 20210039987A
Authority
KR
South Korea
Prior art keywords
tipipanib
mixture
racemic
acid
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020207036324A
Other languages
English (en)
Korean (ko)
Inventor
핑다 렌
샤오후 딩
완핑 메이
Original Assignee
쿠라 온콜로지, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 쿠라 온콜로지, 인크. filed Critical 쿠라 온콜로지, 인크.
Publication of KR20210039987A publication Critical patent/KR20210039987A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B55/00Racemisation; Complete or partial inversion
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00Separation of optically-active compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1020207036324A 2018-05-18 2019-05-17 티피파닙의 합성 Withdrawn KR20210039987A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862673693P 2018-05-18 2018-05-18
US62/673,693 2018-05-18
PCT/US2019/032765 WO2019222565A1 (en) 2018-05-18 2019-05-17 Synthesis of tipifarnib

Publications (1)

Publication Number Publication Date
KR20210039987A true KR20210039987A (ko) 2021-04-12

Family

ID=66770583

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020207036324A Withdrawn KR20210039987A (ko) 2018-05-18 2019-05-17 티피파닙의 합성

Country Status (13)

Country Link
US (1) US11542244B2 (https=)
EP (1) EP3793966A1 (https=)
JP (1) JP2021526513A (https=)
KR (1) KR20210039987A (https=)
CN (1) CN112424149B (https=)
AU (1) AU2019270163A1 (https=)
BR (1) BR112020023559A2 (https=)
CA (1) CA3100706A1 (https=)
EA (1) EA202092787A1 (https=)
MX (1) MX2020012305A (https=)
PH (1) PH12020551956A1 (https=)
SG (1) SG11202011378WA (https=)
WO (1) WO2019222565A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240136572A (ko) 2023-03-07 2024-09-19 단국대학교 천안캠퍼스 산학협력단 티피파르닙을 유효성분으로 포함하는 근감소증 예방 또는 치료용 약학 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE214695T1 (de) 1994-09-23 2002-04-15 Darwin Discovery Ltd Racemisierungsverfahren bei der herstellung von levobupivacaine und analogen
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds
DE69620445T2 (de) 1995-12-08 2002-12-12 Janssen Pharmaceutica N.V., Beerse (imidazol-5-yl)methyl-2-chinolinoderivate als farnesyl protein transferase inhibitoren
BRPI0208075B8 (pt) * 2001-03-12 2021-05-25 Janssen Pharmaceutica Nv processo para a preparação de compostos de imidazol
DE602005007604D1 (de) * 2004-05-03 2008-07-31 Janssen Pharmaceutica Nv Diastereoselektive addition von lithiiertem n-methylimidazol an sulfinimine
JP5008554B2 (ja) * 2004-05-03 2012-08-22 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ イミダゾール化合物の製造用のジアステレオ選択的合成方法
CN100567291C (zh) * 2004-05-03 2009-12-09 詹森药业有限公司 用6-溴-4-(3-氯苯基)-2-甲氧基喹啉进行的非对映选择性合成方法
EP3221311B1 (en) * 2014-11-21 2019-10-30 Merck Patent GmbH Method for the production of praziquantel
CN104876856B (zh) 2015-05-05 2017-11-21 河北凯力昂生物科技有限公司 一种拆分法制备(r)‑(+)‑3‑氨基哌啶二盐酸盐的方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240136572A (ko) 2023-03-07 2024-09-19 단국대학교 천안캠퍼스 산학협력단 티피파르닙을 유효성분으로 포함하는 근감소증 예방 또는 치료용 약학 조성물

Also Published As

Publication number Publication date
JP2021526513A (ja) 2021-10-07
PH12020551956A1 (en) 2021-08-16
CA3100706A1 (en) 2019-11-21
US20210246114A1 (en) 2021-08-12
EA202092787A1 (ru) 2021-02-09
MX2020012305A (es) 2021-03-25
AU2019270163A1 (en) 2020-12-03
CN112424149A (zh) 2021-02-26
CN112424149B (zh) 2023-06-23
EP3793966A1 (en) 2021-03-24
SG11202011378WA (en) 2020-12-30
US11542244B2 (en) 2023-01-03
WO2019222565A1 (en) 2019-11-21
BR112020023559A2 (pt) 2021-02-09

Similar Documents

Publication Publication Date Title
EP3174855B1 (en) Coformer salts of (2s,3s)-methyl 7-fluoro-2-(4-fluorophenyl)-3-(1-methyl-1h-1,2,4-triazol-5-yl)-4-oxo-1,2,3,4-tetrahydroquinoline-5-carboxylate and methods of preparing them
WO2009070314A2 (en) Crystalline form of sitagliptin
JP5503546B2 (ja) 4,5−ジメトキシ−1−(メチルアミノメチル)−ベンゾシクロブタンの分離
US20090124811A1 (en) Method for resolving omeprazole salts
JP5654462B2 (ja) 貧溶媒添加法による2−(3−シアノ−4−イソブチルオキシフェニル)−4−メチル−5−チアゾールカルボン酸の結晶多形体の製造方法
US20110207928A1 (en) Purification method for adefovir dipivoxil
WO2007109799A2 (en) Polymorphs of eszopiclone malate
CN110891947A (zh) 制备艾乐替尼或其药学上可接受的盐的方法
CN101262856A (zh) 唑来膦酸的结晶三水合物
KR20210039987A (ko) 티피파닙의 합성
WO2010027848A2 (en) Forms of lapatinib compounds and processes for the preparation thereof
JP7432503B2 (ja) 塩酸メフパリブの多形体およびその製造方法と使用
JP2013527239A (ja) イクサベピロンの固体形
JP2005506969A (ja) R−チオクト酸のトロメタモル塩の新規変態およびその製法
EA042764B1 (ru) Способы получения (r)-(+)-типифарниба
JP6317358B2 (ja) L‐リジンを含む(3s,3s’)4,4’‐ジスルファンジイルビス(3‐アミノブタン1‐スルホン酸)の新規結晶相
JP5952748B2 (ja) フタロイルアムロジピンの新規結晶形態およびそれを用いる高純度なアムロジピンベシル酸塩の製造方法
JP7042359B2 (ja) ネリドロン酸ナトリウムの多形とその調製過程
JP4402361B2 (ja) 塩酸エピナスチンの結晶多形
EP2610239A1 (en) Preparation Of Rasagiline Hemitartrate
CN111320596A (zh) 盐酸美呋哌瑞多晶型物及其制备方法
JP4168416B2 (ja) 光学活性アミノペンタンニトリルの製造方法
CN109689620A (zh) 拆分巴氯芬盐的方法
WO2024140870A1 (zh) 一种拆分雷米普利中间体的方法
CA3268861A1 (en) Novel co-crystal of enavogliflozin

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PC1202 Submission of document of withdrawal before decision of registration

St.27 status event code: N-1-6-B10-B11-nap-PC1202

WITB Written withdrawal of application
R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000